This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paul, M.
Right arrow Articles by Szczapa, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paul, M.
Right arrow Articles by Szczapa, J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, May 2001, p. 1912-1916, Vol. 39, No. 5
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.5.1912-1916.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Prevalence of Congenital Toxoplasma gondii Infection among Newborns from the Poznań Region of Poland: Validation of a New Combined Enzyme Immunoassay for Toxoplasma gondii-Specific Immunoglobulin A and Immunoglobulin M Antibodies

Małgorzata Paul,1,* Eskild Petersen,2 and Jerzy Szczapa3

Department of Parasitic and Tropical Diseases, Institute of Microbiology and Infectious Diseases,1 and Department of Neonatal Infectious Diseases, Hospital of Gynaecology and Obstetrics,3 Karol Marcinkowski University of Medical Sciences, Poznan, Poland, and Department of Mycobacteria and Parasitic Infections and WHO/FAO International Collaborating Center for Research and Reference on Toxoplasmosis, Statens Serum Institut, Copenhagen, Denmark2

Received 1 November 2000/Returned for modification 2 January 2001/Accepted 7 February 2001

We determined the value of a new serological assay detecting Toxoplasma-specific immunoglobulin M (IgM) and IgA antibodies at birth for use in mass neonatal screening. The incidence of congenital infection in newborns was compared with data from an epidemiological investigation on the seroprevalence of Toxoplasma in the studied population. Peripheral blood was collected on Guthrie cards during the first 3 days of life and tested for anti-Toxoplasma IgA and IgM using a noncommercial immunocapture enzyme-linked immunosorbent assay (ELISA). When the screening assay was positive, serum samples from the child and the mother were collected for use in Western blotting comparative immunological profile analysis and traditional serological tests for determination of specific IgG, IgM, and IgA antibodies. From December 1998 to April 2000, 17,653 filter paper samples from live-born neonates were successively screened. Congenital T. gondii infection was finally confirmed in 19 newborns. In traditional assays, 13 of 19 infants were IgM and IgA positive using filter paper eluates at birth, 1 child was positive only for IgM, 1 patient was positive for IgM and borderline for IgA, 1 had an equivocal level of IgA, and 3 cases were confirmed only by the Western blot assay. The prevalence of Toxoplasma-specific IgA and/or IgM in filter paper samples at birth was 1 per 929 live-born neonates (1.08/1,000) or about 1 per 523 children (1.9/1,000) born to nonimmune women with a potential risk of primary T. gondii infection during pregnancy, compared to the actual seropositivity rate of 43.7%. The diagnostic sensitivity of the combined IgA-IgM ELISA using neonatal filter paper specimens was not more than 95%, the positive predictive value of the test was 82.6%, and the diagnostic specificity was calculated to be 99.9%. The combined IgA-IgM ELISA is a valuable method for the diagnosis of congenital toxoplasmosis at birth and fulfills criteria for neonatal screening programs. The method showed a good diagnostic sensitivity in neonates untreated prenatally who were born in an area of high seroprevalence of T. gondii infection.


* Corresponding author. Mailing address: Department of Parasitic and Tropical Diseases, Institute of Microbiology and Infectious Diseases, Karol Marcinkowski University of Medical Sciences, Przybyszewskiego 49, 60-355 Poznan, Poland. Phone: (48) 618691363. Fax: (48) 618691699. E-mail: mpaul{at}eucalyptus.usoms.poznan.pl.


Journal of Clinical Microbiology, May 2001, p. 1912-1916, Vol. 39, No. 5
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.5.1912-1916.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Lafferty, K. D (2006). Can the common brain parasite, Toxoplasma gondii, influence human culture?. Proc R Soc B 273: 2749-2755 [Abstract] [Full Text]  
  • Gilbert, R, Dezateux, C (2006). Newborn screening for congenital toxoplasmosis: feasible, but benefits are not established.. Arch. Dis. Child. 91: 629-631 [Full Text]  
  • Nowakowska, D., Colon, I., Remington, J. S., Grigg, M., Golab, E., Wilczynski, J., Sibley, L. D. (2006). Genotyping of Toxoplasma gondii by Multiplex PCR and Peptide-Based Serological Testing of Samples from Infants in Poland Diagnosed with Congenital Toxoplasmosis. J. Clin. Microbiol. 44: 1382-1389 [Abstract] [Full Text]  
  • Sorensen, T., Spenter, J., Jaliashvili, I., Christiansen, M., Norgaard-Pedersen, B., Petersen, E. (2002). Automated Time-resolved Immunofluorometric Assay for Toxoplasma gondii-specific IgM and IgA Antibodies: Study of More Than 130 000 Filter-Paper Blood-Spot Samples from Newborns. Clin. Chem. 48: 1981-1986 [Abstract] [Full Text]